The authors suggested that silica-induced lung fibrosis is driven by important crosstalk between the p53-uPA fibrinolytic system in AT2 cells and provide support for a novel pharmacologic target (i.e., CSP), in modulating this pathway. Here, PLAU is linked to pulmonary fibrosis.